Anthera Pharmaceuticals ANTH Stock
Anthera Pharmaceuticals Price Chart
Anthera Pharmaceuticals ANTH Financial and Trading Overview
| Anthera Pharmaceuticals stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0001 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0001 - 0.0001 USD |
| 52 Week Range | 1.0E-5 - 0.0002 USD |
| Volume | 200 USD |
| Avg. Volume | 116 USD |
| Market Cap | 617.83K USD |
| Beta (5Y Monthly) | -109.90493 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ANTH Valuation Measures
| Enterprise Value | -8083382 USD |
| Trailing P/E | N/A |
| Forward P/E | -6.493506E-5 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.00047846886 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.222 |
Trading Information
Anthera Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | -109.90493 |
| 52-Week Change | -50.00000000000000000000000000000000% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0002 USD |
| 52 Week Low | 1.0E-5 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 0.0001 USD |
ANTH Share Statistics
| Avg. Volume (3 month) | 116 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 26.18M |
| Float | 26.13M |
| Short Ratio | 2.09 |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | 2.02M |
| Short % of Float | 10.44% |
| Short % of Shares Outstanding | 7.70% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2017 |
| Most Recent Quarter (mrq) | March 31, 2018 |
| Next Fiscal Year End | December 31, 2018 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -141.96% |
| Return on Equity (ttm) | -568.84% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -28494000 USD |
| EBITDA | -36402000 USD |
| Net Income Avi to Common (ttm) | -24931000 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 8.09M USD |
| Total Cash Per Share (mrq) | 0.31 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.303 |
| Book Value Per Share (mrq) | 0.209 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -31952000 USD |
| Levered Free Cash Flow (ttm) | -17919376 USD |
Profile of Anthera Pharmaceuticals
| Country | United States |
| State | TX |
| City | Houston |
| Address | The Pennzoil Building |
| ZIP | 77002 |
| Phone | 410 350 1839 |
| Website | https://www.anthera.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 21 |
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas.
Q&A For Anthera Pharmaceuticals Stock
What is a current ANTH stock price?
Anthera Pharmaceuticals ANTH stock price today per share is 0.0001 USD.
How to purchase Anthera Pharmaceuticals stock?
You can buy ANTH shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Anthera Pharmaceuticals?
The stock symbol or ticker of Anthera Pharmaceuticals is ANTH.
Which industry does the Anthera Pharmaceuticals company belong to?
The Anthera Pharmaceuticals industry is Biotechnology.
How many shares does Anthera Pharmaceuticals have in circulation?
The max supply of Anthera Pharmaceuticals shares is 6.18B.
What is Anthera Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Anthera Pharmaceuticals PE Ratio is now.
What was Anthera Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Anthera Pharmaceuticals EPS is -0.01 USD over the trailing 12 months.
Which sector does the Anthera Pharmaceuticals company belong to?
The Anthera Pharmaceuticals sector is Healthcare.
Anthera Pharmaceuticals ANTH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite Total Return I XCMP | 21356.17 USD — |
+0.87
|
— — | 20988.36 USD — | 21425.55 USD — | — - | — — |
| NASDAQ Biotechnology Total Retu XNBI | 4471.71 USD — |
-2.63
|
— — | 4460.14 USD — | 4595.5 USD — | — - | — — |
- {{ link.label }} {{link}}